Piramal Enterprises has raised funds through allotment of 3,000 secured, rated, listed, redeemable non-convertible debentures (NCDs) each having a face value of Rs 10 lakh aggregating to Rs 300 crore on private placement basis. The Administrative Committee of Board of Directors of the Company at its meeting held on January 21, 2020 has allotted the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.